AF
Amy C. Fan
University of California, San Francisco, Broad Institute, Stanford University, Massachusetts Institute of Technology
Research areas: Medicine · Oncology · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers · Acute Myeloid Leukemia Research
0000-0003-1612-1862
Employment
-
University of California, San Francisco Postdoctoral Fellow2023 - Present
-
Broad Institute of MIT & Harvard Academic Research Technician2015 - 2016
Education
- 2016 - Present
- 2011 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (145)
- Launching an independent research laboratory and scientific career: Tools for a rapidly changing landscape Save
- Macrophages transfer functional proteins to their surface during live-cell uptake Save
- Submicrometre sampling of living cells by macrophages Save
- DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Data from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Data S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Figures S1-S11 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S7 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save
- Supplementary Table S8 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency Save